Advertisement

Drugs & Therapy Perspectives

, Volume 35, Issue 10, pp 481–484 | Cite as

Treat childhood vitiligo with topical corticosteroids, topical calcineurin inhibitors and/or targeted phototherapy

  • Adis Medical WritersEmail author
Disease Management
  • 10 Downloads

Abstract

Vitiligo, which manifests as varying sizes and shapes of well-circumscribed amelanotic macules or patches amid normally pigmented skin, has a quite common onset during childhood. The most common treatments of childhood vitiligo are topical corticosteroids, topical calcineurin inhibitors and targeted phototherapy. Adequate sun protection and cosmetic camouflage may also be of benefit. It is also important to identify individuals in need of psychological support, as childhood vitiligo can negatively impact psychosocial factors and health-related quality of life.

Notes

Compliance with ethical standards

Funding

The preparation of this review was not supported by any external funding.

Conflict of interest

The article was adapted from the American Journal of Clinical Dermatology 2019; doi:  https://doi.org/10.1007/s40257-019-00430-0 by employees of Adis International Ltd./Springer Nature, who are responsible for the article content and declare no conflicts of interest.

References

  1. 1.
    Nicolaidou E, Mastraftsi S, Tzanetakou V, et al. Childhood vitiligo. Am J Clin Dermatol. 2019.  https://doi.org/10.1007/s40257-019-00430-0.CrossRefPubMedGoogle Scholar
  2. 2.
    Taieb A, Alomar A, Bohm M, et al. Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol. 2013;168(1):5–19.CrossRefPubMedGoogle Scholar
  3. 3.
    Kwinter J, Pelletier J, Khambalia A, et al. High-potency steroid use in children with vitiligo: a retrospective study. J Am Acad Dermatol. 2007;56(2):236–41.CrossRefPubMedGoogle Scholar
  4. 4.
    Ho N, Pope E, Weinstein M, et al. A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0.1% vs. clobetasol propionate 0.05% in childhood vitiligo. Br J Dermatol. 2011;165(3):626–32.CrossRefPubMedGoogle Scholar
  5. 5.
    Kose O, Arca E, Kurumlu Z. Mometasone cream versus pimecrolimus cream for the treatment of childhood localized vitiligo. J Dermatol Treat. 2010;21(3):133–9.CrossRefGoogle Scholar
  6. 6.
    Kanwar AJ, Dogra S. Narrow-band UVB for the treatment of generalized vitiligo in children. Clin Exp Dermatol. 2005;30(4):332–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol. 2000;42(2 Pt 1):245–53.CrossRefPubMedGoogle Scholar
  8. 8.
    Percivalle S, Piccinno R, Caccialanza M, et al. Narrowband ultraviolet B phototherapy in childhood vitiligo: evaluation of results in 28 patients. Pediatr Dermatol. 2012;29(2):160–5.CrossRefPubMedGoogle Scholar
  9. 9.
    Cho S, Zheng Z, Park YK, et al. The 308-nm excimer laser: a promising device for the treatment of childhood vitiligo. Photodermatol Photoimmunol Photomed. 2011;27(1):24–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Koh MJ, Mok ZR, Chong WS. Phototherapy for the treatment of vitiligo in Asan children. Pediatr Dermatol. 2015;32(2):192–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Springer NatureAucklandNew Zealand

Personalised recommendations